Literature DB >> 6110244

Paradoxical elevation of growth hormone by intraventricular somatostatin: possible ultrashort-loop feedback.

M D Lumpkin, A Gegro-Vilar, S M McCann.   

Abstract

Somatostatin, the growth hormone-inhibiting factor, when microinjected into the third ventricle of the rat brain, paradoxically induced the release of growth hormone. A pituitary site of action having been ruled out, this result supports the concept that exogenous somatostatin within the hypothalamus acts either to suppress the release of somatostatin from somatostatin-containing neurons, possibly via an ultrashort-loop feedback mechanism, or to augment release of hypothalamic growth hormone-releasing factor, thereby inducing a release of growth hormone. Injection of somatostatin into the third ventricle also decreased plasma concentrations of luteinizing hormone, follicle-stimulating hormone, and thyroid-stimulating hormone, probably by inhibiting the release of luteinizing hormone-releasing factor and thyrotropin-releasing factor.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6110244     DOI: 10.1126/science.6110244

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  9 in total

1.  Immunohistochemical and cytochemical localization of the somatostatin receptor subtype sst1 in the somatostatinergic parvocellular neuronal system of the rat hypothalamus.

Authors:  L Helboe; C E Stidsen; M Moller
Journal:  J Neurosci       Date:  1998-07-01       Impact factor: 6.167

2.  Synaptic communication between somatostatinergic axons and growth hormone-releasing factor (GRF) synthesizing neurons in the arcuate nucleus of the rat.

Authors:  Z Liposits; I Merchenthaler; W K Paull; B Flerkó
Journal:  Histochemistry       Date:  1988

3.  Ultrashort-loop positive feedback of corticotropin (ACTH)-releasing factor to enhance ACTH release in stress.

Authors:  N Ono; J C Bedran de Castro; S M McCann
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

4.  Somatostatin inhibits in vitro release of luteinizing hormone releasing hormone from rat mediobasal hypothalamic slices.

Authors:  W H Rotsztejn; S V Drouva; J Epelbaum; C Kordon
Journal:  Experientia       Date:  1982-08-15

Review 5.  Progress in neuroendocrinology: LH releasing (LHRH), basic and clinical aspects.

Authors:  S M McCann
Journal:  J Endocrinol Invest       Date:  1983-06       Impact factor: 4.256

6.  The influence of human corticotropin-releasing hormone on somatostatin secretion in depressed patients and controls.

Authors:  K P Lesch; E Widerlöv; R Ekman; G Laux; R Rupprecht; H M Schulte; H Beckmann
Journal:  J Neural Transm       Date:  1989       Impact factor: 3.575

7.  Expression of gonadotropin-releasing hormone receptors and autocrine regulation of neuropeptide release in immortalized hypothalamic neurons.

Authors:  L Z Krsmanović; S S Stojilković; L M Mertz; M Tomić; K J Catt
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-01       Impact factor: 11.205

8.  Somatostatin release from dispersed hypothalamic cells: effects of diabetes.

Authors:  S B Richardson; S Twente
Journal:  Diabetologia       Date:  1987-11       Impact factor: 10.122

9.  Growth hormone-releasing factor increases somatostatin release and mRNA levels in the rat periventricular nucleus via nitric oxide by activation of guanylate cyclase.

Authors:  M C Aguila
Journal:  Proc Natl Acad Sci U S A       Date:  1994-01-18       Impact factor: 11.205

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.